The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
TNGX · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
NVNO · Healthcare · No moat
Doesn't clear the bar
The businessTrend component abstained: Fewer than two aligned fiscal years of revenue and diluted EPS are available; the filing history does not contain a measurable trend. The other four 20% weights were renormalized over the scored 80%.
| Measure | TNGX | SNOA | NVNO | INIS |
|---|---|---|---|---|
| Moat Score (0–100) | 39 (highest) | 39 (highest) | 39 (highest) | 38 |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 55 | 39 | — | 56 (highest) |
| Pricing power | — | 54 | 55 | 84 (highest) |
| Returns on capital | 0 (highest) | 0 (highest) | 0 (highest) | 0 (highest) |
| Balance-sheet safety | 55 (highest) | 55 (highest) | 55 (highest) | 28 |
| Capital discipline | 44 (highest) | 44 (highest) | 44 (highest) | 24 |
| Price vs. high estimate | No price data | No price data | No price data | No price data |
| Market cap | $3.7B | $2.1M | $7.2M | $37.0M |
| Moat tier | No moat | No moat | No moat | No moat |
| Filings as of | FY2025 | FY2026 | FY2025 | FY2025 |